ELIZABETH MILLER: Open Payments
NPI 1699498022 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 16 payments from 10 companies in 2025. Trend: 2023 $138 · 2024 $317 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $154 |
| HEARTFLOW, INC. | 1 | $146 |
| E.R. Squibb & Sons, L.L.C. | 2 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $76 |
| BridgeBio Pharma, Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
Products named: REPATHA, FFRct, Kerendia, Attruby, XYWAV, LEQVIO, CAMZYOS, FUROSCIX.
Industry payments across NE — which companies pay providers there.
